Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$1.45
-1.0%
$1.51
$1.21
$3.99
$31.14M2.2127,995 shs4,272 shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$13.35
-4.0%
$15.04
$12.76
$27.28
$132.35M1.01126,216 shs108,701 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.61
-12.5%
$2.91
$1.59
$9.37
$74.07M0.43649,469 shs1.87 million shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.44
-20.3%
$3.05
$2.37
$7.24
$117.24M0.62138,464 shs1.72 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-1.03%-7.37%-3.67%+6.64%-32.48%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-4.03%-10.76%-2.20%-20.72%-43.43%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-12.50%-51.80%-40.81%-57.29%-76.70%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-20.26%-25.84%-15.28%-10.95%-66.94%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
1.9169 of 5 stars
3.52.00.00.00.43.30.0
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.7261 of 5 stars
3.51.00.84.92.63.32.5
Pulmonx Corporation stock logo
LUNG
Pulmonx
3.8335 of 5 stars
4.33.00.00.02.33.31.3
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.438 of 5 stars
3.63.00.00.02.51.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
3.00
Buy$9.25540.14% Upside
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
3.00
Buy$26.0094.76% Upside
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.56
Moderate Buy$7.66376.04% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
3.20
Buy$14.00473.77% Upside

Current Analyst Ratings Breakdown

Latest COCH, LAKE, LUNG, and OBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $5.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $16.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$9.00 ➝ $2.50
6/10/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$30.00 ➝ $26.00
5/27/2025
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$9.25 ➝ $9.50
5/22/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.15
5/13/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
5/5/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$220K140.10N/AN/A($0.88) per share-1.64
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$167.21M0.76$1.02 per share13.03$15.44 per share0.86
Pulmonx Corporation stock logo
LUNG
Pulmonx
$83.79M0.77N/AN/A$2.17 per share0.74
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.64M35.41N/AN/A$0.87 per share2.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-$20.80M-$1.38N/AN/AN/A-10,961.26%N/A-233.08%8/11/2025 (Estimated)
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$18.08M-$3.01N/A8.04N/A-13.31%-6.88%-4.47%9/3/2025 (Estimated)
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$56.39M-$1.43N/AN/AN/A-62.88%-66.36%-35.51%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$61.02M-$1.78N/AN/AN/A-2,297.85%-189.26%-93.76%N/A

Latest COCH, LAKE, LUNG, and OBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025N/A
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-$0.30N/AN/AN/AN/AN/A
7/31/2025Q2 2025
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-$0.29-$0.32-$0.03-$0.32$0.07 million$0.08 million
7/30/2025Q2 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 million
6/9/2025Q1 2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.27-$0.41-$0.68-$0.41$48.84 million$46.75 million
5/12/2025Q1 2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.46-$0.49-$0.03-$0.49$0.39 million$0.87 million
5/7/2025Q1 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.90%N/AN/A 1 Years
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
N/A
1.09
0.88
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.17
3.88
1.51
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.38
4.97
4.29
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
0.85
3.35
3.34

Institutional Ownership

CompanyInstitutional Ownership
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
8.59%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.55%

Insider Ownership

CompanyInsider Ownership
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
58.90%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1.91%
Pulmonx Corporation stock logo
LUNG
Pulmonx
6.80%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
3421.33 million8.77 millionNot Optionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2,1009.51 million9.33 millionOptionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25040.26 million37.52 millionOptionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
438.31 million35.21 millionNot Optionable

Recent News About These Companies

Orchestra BioMed prices $40M offering, amends Medtronic deal
Orchestra BioMed Announces Proposed Public Offering

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Envoy Medical stock logo

Envoy Medical NASDAQ:COCH

$1.44 -0.02 (-1.03%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$1.46 +0.02 (+1.38%)
As of 08/1/2025 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Lakeland Industries stock logo

Lakeland Industries NASDAQ:LAKE

$13.35 -0.56 (-4.03%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$13.36 +0.01 (+0.04%)
As of 08/1/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$1.61 -0.23 (-12.50%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.67 +0.06 (+3.66%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$2.44 -0.62 (-20.26%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.47 +0.03 (+1.23%)
As of 08/1/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.